Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$7.6 - $11.41 $653,303 - $980,815
85,961 Added 7.69%
1,204,028 $11.7 Million
Q1 2022

May 16, 2022

BUY
$9.3 - $12.37 $5.41 Million - $7.19 Million
581,329 Added 108.31%
1,118,067 $11.1 Million
Q4 2021

Feb 14, 2022

BUY
$10.39 - $15.15 $589,507 - $859,580
56,738 Added 11.82%
536,738 $6.32 Million
Q3 2021

Nov 15, 2021

BUY
$11.39 - $16.23 $5.47 Million - $7.79 Million
480,000 New
480,000 $5.47 Million

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.